Transcripts of BCR–ABL were comparable between Evi1-high and Evi1-low LSK populations (Figure 2d), suggesting little relevance of BCR–ABL to the enhanced proliferation of Evi1-high CML cells. The gene discussed is MECOM; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.